The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
The Bioavailability of Drugs—The Current State of Knowledge
Open accessAbstract
Drug bioavailability is a crucial aspect of pharmacology, affecting the effectiveness of drug therapy. Understanding how drugs are absorbed, distributed, metabolized, and eliminated in patients’ bodies is essential to ensure proper and safe treatment. This publication aims to highlight the relevance of drug bioavailability research and its importance in therapy. In addition to biochemical activity, bioavailability also plays a critical role in achieving the desired therapeutic effects. This may seem obvious, but it is worth noting that a drug can only produce the expected effect if the proper level of concentration can be achieved at the desired point in a patient’s body. Given the differences between patients, drug dosages, and administration forms, understanding and controlling bioavailability has become a priority in pharmacology. This publication discusses the basic concepts of bioavailability and the factors affecting it. We also looked at various methods of assessing bioavailability, both in the laboratory and in the clinic. Notably, the introduction of new technologies and tools in this field is vital to achieve advances in drug bioavailability research. This publication also discusses cases of drugs with poorly described bioavailability, providing a deeper understanding of the complex challenges they pose to medical researchers and practitioners. Simultaneously, the article focuses on the perspectives and trends that may shape the future of research regarding bioavailability, which is crucial to the development of modern pharmacology and drug therapy. In this context, the publication offers an essential, meaningful contribution toward understanding and highlighting bioavailability’s role in reliable patient treatment. The text also identifies areas that require further research and exploration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · International Journal of Surgery · doi:10.1016/j.ijsu.2021.105906 · Cited by 11,748
Patel, M., Kumar, R., Kishor, K., Mlsna, T., Pittman, C. U., & Mohan, D. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00299 · Cited by 2,654
A blood–brain barrier overview on structure, function, impairment, and biomarkers of integrity
Kadry, H., Noorani, B., & Cucullo, L. (2020) · Fluids and Barriers of the CNS · doi:10.1186/s12987-020-00230-3 · Cited by 1,853
The current landscape of nucleic acid therapeutics
Kulkarni, J. A., Witzigmann, D., Thomson, S. B., Chen, S., Leavitt, B. R., Cullis, P. R., & van der Meel, R. (2021) · Nature Nanotechnology · doi:10.1038/s41565-021-00898-0 · Cited by 1,371
Advances in Oral Drug Delivery
Alqahtani, M. S., Kazi, M., Alsenaidy, M. A., & Ahmad, M. Z. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.618411 · Cited by 876
Recent progress in drug delivery
Li, C., Wang, J., Wang, Y., Gao, H., Wei, G., Huang, Y., Yu, H., Gan, Y., Wang, Y., Mei, L., et al. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.08.003 · Cited by 818
Sex differences in pharmacokinetics predict adverse drug reactions in women
Zucker, I., & Prendergast, B. J. (2020) · Biology of Sex Differences · doi:10.1186/s13293-020-00308-5 · Cited by 777
The blood-brain barrier: Physiology and strategies for drug delivery
Pandit, R., Chen, L., & Götz, J. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.11.009 · Cited by 651
Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles
Singh, A. P., Biswas, A., Shukla, A., & Maiti, P. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0068-3 · Cited by 645
Cancer Metabolism: Phenotype, Signaling and Therapeutic Targets
Park, J. H., Pyun, W. Y., & Park, H. W. (2020) · Cells · doi:10.3390/cells9102308 · Cited by 548
Martinez, M. N., & Amidon, G. L. (2002) · The Journal of Clinical Pharmacology · doi:10.1177/00970002042006005 · Cited by 536
Rabbani, G., & Ahn, S. N. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.11.053 · Cited by 505
Shultz, M. D. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00686 · Cited by 434
Current trends in drug metabolism and pharmacokinetics
Li, Y., Meng, Q., Yang, M., Liu, D., Hou, X., Tang, L., Wang, X., Lyu, Y., Chen, X., Liu, K., et al. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.10.001 · Cited by 391
The mechanisms of pharmacokinetic food-drug interactions – A perspective from the UNGAP group
Koziolek, M., Alcaro, S., Augustijns, P., Basit, A. W., Grimm, M., Hens, B., Hoad, C. L., Jedamzik, P., Madla, C. M., Maliepaard, M., et al. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2019.04.003 · Cited by 385
Drug Metabolites in Safety Testing
Baillie, T. (2002) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2002.9440 · Cited by 371
Vinarov, Z., Abdallah, M., Agundez, J. A. G., Allegaert, K., Basit, A. W., Braeckmans, M., Ceulemans, J., Corsetti, M., Griffin, B. T., Grimm, M., et al. (2021) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2021.105812 · Cited by 359
Apixaban: A Clinical Pharmacokinetic and Pharmacodynamic Review
Byon, W., Garonzik, S., Boyd, R. A., & Frost, C. E. (2019) · Clinical Pharmacokinetics · doi:10.1007/s40262-019-00775-z · Cited by 348
Machine learning directed drug formulation development
Bannigan, P., Aldeghi, M., Bao, Z., Häse, F., Aspuru-Guzik, A., & Allen, C. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.05.016 · Cited by 335
Impact of gastrointestinal physiology on drug absorption in special populations––An UNGAP review
Stillhart, C., Vučićević, K., Augustijns, P., Basit, A. W., Batchelor, H., Flanagan, T. R., Gesquiere, I., Greupink, R., Keszthelyi, D., Koskinen, M., et al. (2020) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2020.105280 · Cited by 320
Recent developments in the detection of bovine serum albumin
Jahanban-Esfahlan, A., Ostadrahimi, A., Jahanban-Esfahlan, R., Roufegarinejad, L., Tabibiazar, M., & Amarowicz, R. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.07.096 · Cited by 304
The Promise of Nanotechnology in Personalized Medicine
Alghamdi, M. A., Fallica, A. N., Virzì, N., Kesharwani, P., Pittalà, V., & Greish, K. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12050673 · Cited by 284
In Vivo Methods for the Assessment of Topical Drug Bioavailability
Herkenne, C., Alberti, I., Naik, A., Kalia, Y. N., Mathy, F.-X., Préat, V., & Guy, R. H. (2008) · Pharmaceutical Research · doi:10.1007/s11095-007-9429-7 · Cited by 260
Unlocking the Power of Exosomes for Crossing Biological Barriers in Drug Delivery
Elliott, R. O., & He, M. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13010122 · Cited by 260
Bohn, T., Desmarchelier, C., Dragsted, L. O., Nielsen, C. S., Stahl, W., Rühl, R., Keijer, J., & Borel, P. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600685 · Cited by 249
Selyutina, O. Y., & Polyakov, N. E. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.01.047 · Cited by 246
The influence of the gut microbiota on the bioavailability of oral drugs
Zhang, X., Han, Y., Huang, W., Jin, M., & Gao, Z. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.09.013 · Cited by 242
Tuntland, T., Ethell, B., Kosaka, T., Blasco, F., Zang, R. X., Jain, M., Gould, T., & Hoffmaster, K. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00174 · Cited by 239 · cited 3×
“Therefore, pharmacokinetic studies, which measure bioavailability, are required before a drug can be marketed [20].”
BackgroundInfluentialDrenth‐van Maanen, A. C., Wilting, I., & Jansen, P. A. F. (2020) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14094 · Cited by 237
In-vitro blood-brain barrier models for drug screening and permeation studies: an overview
Bagchi, S., Chhibber, T., Lahooti, B., Verma, A., Borse, V., & Jayant, R. D. (2019) · Drug Design, Development and Therapy · doi:10.2147/dddt.s218708 · Cited by 234
Yang, F., Bian, C., Zhu, L., Zhao, G., Huang, Z., & Huang, M. (2007) · Journal of Structural Biology · doi:10.1016/j.jsb.2006.08.015 · Cited by 228
Mechanism of a long-term controlled drug release system based on simple blended electrospun fibers
Wu, J., Zhang, Z., Gu, J., Zhou, W., Liang, X., Zhou, G., Han, C. C., Xu, S., & Liu, Y. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.01.020 · Cited by 227
Fruit juice inhibition of uptake transport: a new type of food–drug interaction
Bailey, D. G. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2010.03722.x · Cited by 222
Review of Current Strategies for Delivering Alzheimer’s Disease Drugs across the Blood-Brain Barrier
Wong, K. H., Riaz, M. K., Xie, Y., Zhang, X., Liu, Q., Chen, H., Bian, Z., Chen, X., Lu, A., & Yang, Z. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020381 · Cited by 213
Intracellular transport and regulation of transcytosis across the blood–brain barrier
Villaseñor, R., Lampe, J., Schwaninger, M., & Collin, L. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2982-x · Cited by 209
The Stages of Drug Discovery and Development Process
Deore, A. B., Dhumane, J. R., Wagh, R., & Sonawane, R. (2019) · Asian Journal of Pharmaceutical Research and Development · doi:10.22270/ajprd.v7i6.616 · Cited by 203
The Influence of Nanoparticle Properties on Oral Bioavailability of Drugs
Wang, Y., Pi, C., Feng, X., Hou, Y., Zhao, L., & Wei, Y. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s257269 · Cited by 199
Gaohua, L., Miao, X., & Dou, L. (2021) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2021.1951223 · Cited by 193
Ahmed Juvale, I. I., Abdul Hamid, A. A., Abd Halim, K. B., & Che Has, A. T. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e09777 · Cited by 190
Comparison of the Accuracy of Experimental and Predicted pKa Values of Basic and Acidic Compounds
Settimo, L., Bellman, K., & Knegtel, R. M. A. (2014) · Pharmaceutical Research · doi:10.1007/s11095-013-1232-z · Cited by 180
Predicting Oral Drug Absorption: Mini Review on Physiologically-Based Pharmacokinetic Models
Lin, L., & Wong, H. (2017) · Pharmaceutics · doi:10.3390/pharmaceutics9040041 · Cited by 172
Sánchez-Félix, M., Burke, M., Chen, H. H., Patterson, C., & Mittal, S. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.05.009 · Cited by 162
Cheng, L., & Wong, H. H. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12070672 · Cited by 161
Caldwell, J., Gardner, I., & Swales, N. (1995) · Toxicologic Pathology · doi:10.1177/019262339502300202 · Cited by 160
Wagner, J. G. (1981) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(81)90097-8 · Cited by 160
Drug Carriers: Classification, Administration, Release Profiles, and Industrial Approach
Trucillo, P. (2021) · Processes · doi:10.3390/pr9030470 · Cited by 151
Pharmacology, Part 2: Introduction to Pharmacokinetics
Currie, G. M. (2018) · Journal of Nuclear Medicine Technology · doi:10.2967/jnmt.117.199638 · Cited by 149
The ABCD of clinical pharmacokinetics
Doogue, M. P., & Polasek, T. M. (2013) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098612469335 · Cited by 140
Gröber, U. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092094 · Cited by 138
O’Laughlin, K., Tobolowsky, F. A., Elmor, R., Overton, R., O’Connor, S. M., Damon, I. K., Petersen, B. W., Rao, A. K., Chatham‐Stephens, K., Yu, P. A., et al. (2022) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7137e1 · Cited by 138
Individualized medicine: Sex, hormones, genetics, and adverse drug reactions
Moyer, A. M., Matey, E. T., & Miller, V. M. (2019) · Pharmacology Research & Perspectives · doi:10.1002/prp2.541 · Cited by 136
Endothelial cell barriers: Transport of molecules between blood and tissues
Yazdani, S., Jaldín‐Fincati, J. R., Pereira, R. V. S., & Klip, A. (2019) · Traffic · doi:10.1111/tra.12645 · Cited by 127
Ginsenosides emerging as both bifunctional drugs and nanocarriers for enhanced antitumor therapies
Wang, H., Zheng, Y., Sun, Q., Zhang, Z., Zhao, M., Peng, C. Y., & Shi, S. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-01062-5 · Cited by 123
Bardelmeijer, H. A., Beijnen, J. H., Brouwer, K. R., Rosing, H., Nooijen, W. J., Schellens, J. H. M., & van Tellingen, O. (2000) · PubMed · Cited by 121
Modern pharmacological treatment of obese patients
May, M., Schindler, C., & Engeli, S. (2020) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018819897527 · Cited by 100
The origins of the circumventricular organs
Kiecker, C. (2018) · Journal of Anatomy · doi:10.1111/joa.12771 · Cited by 92
HobPre: accurate prediction of human oral bioavailability for small molecules
Wei, M., Zhang, X., Pan, X., Wang, B., Ji, C., Qi, Y., & Zhang, J. Z. H. (2022) · Journal of Cheminformatics · doi:10.1186/s13321-021-00580-6 · Cited by 91
Angeles, P. C., Robertsen, I., Seeberg, L. T., Krogstad, V., Skattebu, J., Sandbu, R., Åsberg, A., & Hjelmesaeth, J. S. (2019) · Obesity Reviews · doi:10.1111/obr.12869 · Cited by 87
Nuclear imaging approaches facilitating nanomedicine translation
Pérez‐Medina, C., Teunissen, A. J. P., Kluza, E., Mulder, W. J. M., & van der Meel, R. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.017 · Cited by 85
Alternative Routes of Administration for Therapeutic Antibodies—State of the Art
Pitiot, A., Heuzé‐Vourc'h, N., & Sécher, T. (2022) · Antibodies · doi:10.3390/antib11030056 · Cited by 82
Marković, M., Zur, M., Ragatsky, I., Cvijić, S., & Dahan, A. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12121175 · Cited by 78
An updated patent review on P-glycoprotein inhibitors (2011-2018)
Leopoldo, M., Nardulli, P., Contino, M., Leonetti, F., Luurtsema, G., & Colabufo, N. A. (2019) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2019.1618273 · Cited by 75
Podoll, T., Pearson, P. G., Evarts, J., Ingallinera, T., Бибикова, Е., Sun, H., Gohdes, M. A., Cardinal, K. A., Sanghvi, M., & Slatter, J. G. (2018) · Drug Metabolism and Disposition · doi:10.1124/dmd.118.084459 · Cited by 74
The molecular anatomy and functions of the choroid plexus in healthy and diseased brain
Kratzer, I., Ek, C. J., & Stolp, H. B. (2020) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2020.183430 · Cited by 74
Fuhr, L. M., Marok, F. Z., Hanke, N., Selzer, D., & Lehr, T. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13020270 · Cited by 74
Santbergen, M. J. C., van der Zande, M., Gerssen, A., Bouwmeester, H., & Nielen, M. W. F. (2019) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-019-02336-6 · Cited by 71
The Effect of Coffee on Pharmacokinetic Properties of Drugs : A Review
Belayneh, A., & Molla, F. (2020) · BioMed Research International · doi:10.1155/2020/7909703 · Cited by 70
New Approaches in Oncology for Repositioning Drugs: The Case of PDE5 Inhibitor Sildenafil
Cruz-Burgos, M., Losada-García, A., Cruz-Hernández, C. D., Cortés-Ramírez, S. A., Camacho‐Arroyo, I., González-Covarrubias, V., Morales-Pacheco, M., Trujillo-Bornios, S. I., & Rodríguez‐Dorantes, M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.627229 · Cited by 67
Gut reaction: impact of systemic diseases on gastrointestinal physiology and drug absorption
Hatton, G. B., Madla, C. M., Rabbie, S. C., & Basit, A. W. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.11.009 · Cited by 64
Into the Labyrinth of the Lipocalin α1-Acid Glycoprotein
Ruiz, M. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.686251 · Cited by 63
Shinha, K., Nihei, W., Ono, T., Nakazato, R., & Kimura, H. (2020) · Biomicrofluidics · doi:10.1063/5.0011545 · Cited by 61
Physiological expression and function of the MDR1 transporter in cytotoxic T lymphocytes
Chen, M. L., Sun, A. L., Cao, W., Eliason, A. D., Mendez, K. M., Getzler, A. J., Tsuda, S., Diao, H., Mukori, C., Bruno, N. E., et al. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20191388 · Cited by 54
Levothyroxine therapy in gastric malabsorptive disorders
Virili, C., Brusca, N., Capriello, S., & Centanni, M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.621616 · Cited by 52
Olivares‐Morales, A., Hatley, O. J. D., Turner, D. B., Galetin, A., Aarons, L. J., & Rostami‐Hodjegan, A. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1193-2 · Cited by 49
Nanomedicine of tyrosine kinase inhibitors
Šmídová, V., Michálek, P., Goliášová, Z., Eckschlager, T., Hodek, P., Adam, V., & Heger, Z. (2020) · Theranostics · doi:10.7150/thno.48662 · Cited by 49
Acetylsalicylic Acid–Primus Inter Pares in Pharmacology
Fijałkowski, Ł., Skubiszewska, M., Grześk, G., Koech, F. K., & Nowaczyk, A. (2022) · Molecules · doi:10.3390/molecules27238412 · Cited by 46
Self-citationBioavailability by design — Vitamin D3 liposomal delivery vehicles
Dałek, P., Drabik, D., Wołczańska, H., Foryś, A., Jagas, M., Jędruchniewicz, N., Przybyło, M., Witkiewicz, W., & Langner, M. (2022) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2022.102552 · Cited by 45
Eedara, B. B., Veerareddy, P. R., Jukanti, R., & Bandari, S. (2013) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2013.801984 · Cited by 43
Mechanisms and interactions in concomitant use of herbs and warfarin therapy: An updated review
Leite, P. M., Martins, M. A. P., Ferriani, M. D. G. C., & Castilho, R. O. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112103 · Cited by 43
Fu, C., Shi, H., Chen, H., Zhang, K., Wang, M., & Qiu, F. (2020) · ACS Omega · doi:10.1021/acsomega.0c05465 · Cited by 38
Tanguay, M., Girard, J., Scarsi, C., Mautone, G., & Larouche, R. (2019) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.608 · Cited by 33
Landersdorfer, C. B., Gwee, A., & Nation, R. L. (2023) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2023.04.009 · Cited by 30
Boosting drug bioavailability in men but not women through the action of an excipient
Mai, Y., Ashiru-Oredope, D. A. I., Yao, Z., Dou, L., Madla, C. M., Taherali, F., Murdan, S., & Basit, A. W. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119678 · Cited by 28
Controlled Drug Release of Smart Magnetic Self-Assembled Micelle, Kinetics and Transport Mechanisms
Sulttan, S., & Rohani, S. (2022) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2022.03.023 · Cited by 23
Minuesa, G., Arimany-Nardí, C., Erkizia, I., Cedeño, S., Moltó, J., Clotet, B., Pastor‐Anglada, M., & Martínez‐Picado, J. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw215 · Cited by 21
Optimized In Silico Modeling of Drug Absorption after Gastric Bypass: The Case of Metformin
Dahan, A., Porat, D., Marković, M., Zur, M., Kister, O., & Langguth, P. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13111873 · Cited by 18
Attwa, M. W., Alrabiah, H. K., Mostafa, G. A. E., & Kadi, A. A. (2023) · Molecules · doi:10.3390/molecules28052322 · Cited by 16
Khodov, I. A., Belov, K. V., Sobornova, V. V., et al. (2023) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2023.122620 · Cited by 14
Pai, A. B., Digigow, R. G., Flühmann, B., & Wacker, M. G. (2023) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2023.04.025 · Cited by 12
Effect of dietary supplements on Se bioavailability: A comprehensive in vitro and in vivo study
Zhang, R., Yang, Y., Min, M., & Li, Y. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2022.113193 · Cited by 11
Voronin, A. P., Ramazanova, A. G., Surov, A. O., Churakov, A. V., & Perlovich, G. L. (2023) · Crystal Growth & Design · doi:10.1021/acs.cgd.3c00751 · Cited by 6
Kalaimathi, K., Shine, K., Gandhi, G. R., Vijayakumar, S., Ayyanar, M., Amalraj, S., Varatharaju, G., Thiruvengadam, M., Ceasar, S. A., Prabhu, S., et al. (2023) · Intelligent Pharmacy · doi:10.1016/j.ipha.2023.06.002 · Cited by 3
Cited by
Ghosh, S., Basu, S., Anbarasu, A., & Ramaiah, S. (2025) · Phytotherapy Research · doi:10.1002/ptr.8365 · Cited by 33
Metadata
- Authors
- Stielow, M., Witczyńska, A., Kubryń, N., Fijałkowski, Ł., Nowaczyk, J., & Nowaczyk, A.
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2023-12-11
- Volume
- 28
- Issue
- 24
- Pages
- 8038
- ISSN
- 1420-3049 (ISSN-L)
- OpenAlex
- W4389547140
- Cited by
- 391
- References
- 93
- FWCI
- 33.68
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.